Fritextsökning
Innehållstyper
-
Measure blood sugar without finger pricking
The Danish entrepreneurial firm RSP Systems has developed a method to measure the blood sugar level in diabetes patients, simply by placing a fingertip on a sma...
-
Datainsamling ska underlätta för kliniska studier
Akademiska sjukhuset testar ny lösning för elektronisk datainsamling.
-
Ny chef på Calmark
Michael Lund är ny QA/RA-chef på det Karlstadbaserade företaget.
-
Dako appoints new CEO
The Danish cancer therapeutic company Dako has appointed a new CEO after Patrik Dahlén.
-
New CEO to Promedvi
Sigrun Axelsson has taken on the leadership of the Lund-based medtech company.
-
Pharma is a safe market
Pharma is the best industry to invest in. That states leaders from risk capital companies, interviewed by the Economist Intelligence Unit.
-
Re-painting the big pig-ture
Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.
-
Studie: Barn har oftare antikroppar som korsreagerar med coronaviruset
Enligt en ny studie förekommer det ibland antikroppar hos personer som inte haft covid-19 som korsreagerar med det nya coronaviruset sars-cov-2.
-
Uppsala i toppen när inkubatorer rankas
Uppsala innovation centre har rankats som världens fjärde bästa företagsinkubator med universitetskoppling.
-
Xvivo byter vd
Dag Andersson tar över vd-rollen efter grundaren Magnus Nilsson.
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
Follicum stärker teamet när klinik närmar sig
När bolagets nya läkemedelskandidat närmar sig klinik stärker bolaget upp sin expertis inom diabetes med ett vetenskapligt råd.
-
Glucose facilitates the use of indigo
The Finnish researcher Anne Vuorema oat the MTT Agrifood Research Finland proves in her new doctoral dissertation that glucose can serve as a reducing agent of indigo.
-
DKK 1,3 billion for grand research
Danish Councils for Independent Research, DFF, will grant DKK 1,3 billion during 2009. Now has the application period started.
-
Elyptas cancertest har fått patent i USA
Testet kan tas från urin eller blod och möjliggör en säkrare och billigare metod för upptäckt av njurcancer.
-
Age essential when testing drugs
Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
New member to Active board
The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be ...
-
"Behöver vara enklare för patienter att hitta till lämpliga studier"
Jonas Venge och Ida Solvang båda Site Relationship and Excellence Partner på Pfizer kommenterar SwedenBios förslag om att möjliggöra för fler kliniska prövningar i Sverige.
-
Studie: Linagliptin gav inga hjärt- eller njurskador hos äldre med typ 2-diabetes
En nya studie visar att den aktiva substansen linagliptin (Trajenta) inte ger en högre risk för kardiovaskulära händelser.
-
Woman deficit in Swedish research
The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.
-
Anything is measurable
At the seminar "Du är vad jag mäter - hjärnans kemi i ett provrör", Jonas Bergquist, professor of analytical chemistry and neurochemistry, will dig deep into th...
-
New firm based on SLU research
Four researchers at the Swedish University of Agricultural Sciences, SLU, has recently founded a new nanotech company.
-
New CEO to Medivir
The Board of the Swedish biotech company Medivir has appointed the successor to the current CEO Lars Adlersson.
BREAKING